Panel Discussion: Exploring the Future of Extrahepatic LNPs to Overcome Delivery Barriers, Expand Therapeutic Reach, & Unlock Novel Disease Treatments

2:40 pm - Wednesday 3rd June 2026

  • What are the remaining barriers for achieving efficient, organ-specific delivery to difficult targets?
  • Which design strategies and technologies are most promising for enabling precise extrahepatic targeting while minimizing liver accumulation?
  • What unmet therapeutic needs could next-generation extrahepatic LNPs address to expand the RNA, gene editing, and cell therapy landscape?

Speakers:

Bohdan Andreiuk
Senior Scientist - New Modality Preformulation & Lipid Nano Particle Formulation
AstraZeneca
Pintu Kanjilal
LNP Discovery Scientist
Strand Therapeutics Inc.
Justin Fang
Senior Scientist, Formulations
Mote Therapeutics
Raj Reddy
Chief Executive Officer
Canary Cure Therapeutics
Russell Johnson
Executive Director, Delivery Sciences
Moderna